TNX-102 SL has the potential to be the first member of a new class of analgesic drugs for fibromyalgia and the first new drug for treating fibromyalgia in more than 15 years, if approved by FDA NDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results